These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 25722110)
1. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells. Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of microRNA-messenger RNA regulatory network in gemcitabine-resistant bladder cancer cells. Zhang S; Chang YY; Gong YW; Gao YJ; Guo Q; Wang YH; Zhao YL; Wang ZP J Cell Biochem; 2019 Apr; 120(4):6347-6360. PubMed ID: 30304549 [TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from cancer stem cells of gemcitabine-resistant pancreatic cancer cells enhance drug resistance by delivering miR-210. Yang Z; Zhao N; Cui J; Wu H; Xiong J; Peng T Cell Oncol (Dordr); 2020 Feb; 43(1):123-136. PubMed ID: 31713003 [TBL] [Abstract][Full Text] [Related]
4. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205. Chaudhary AK; Mondal G; Kumar V; Kattel K; Mahato RI Cancer Lett; 2017 Aug; 402():1-8. PubMed ID: 28536008 [TBL] [Abstract][Full Text] [Related]
5. Mechanism Comparison of Gemcitabine and Dasatinib-Resistant Pancreatic Cancer by Integrating mRNA and miRNA Expression Profiles. Chen Z; Zhao L; Shi K; Chen B Clin Lab; 2018 May; 64(5):749-757. PubMed ID: 29739052 [TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells. Xu C; Yu Y; Ding F Oncol Rep; 2018 Jul; 40(1):395-404. PubMed ID: 29781033 [TBL] [Abstract][Full Text] [Related]
7. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro. Liu DL; Bu H; Li H; Chen H; Guo HC; Wang ZH; Tong HF; Ni ZL; Liu HB; Lin SZ Int J Oncol; 2012 Apr; 40(4):1049-57. PubMed ID: 22159556 [TBL] [Abstract][Full Text] [Related]
8. MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20. Yao J; Li Z; Wang X; Xu P; Zhao L; Qian J Acta Biochim Biophys Sin (Shanghai); 2016 Feb; 48(2):202-8. PubMed ID: 26758190 [TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0007401 regulates gemcitabine resistance of pancreatic cancer through the hsa-miR-6509-3p/fli1 axis. Han C; Zheng H; Hu D; Wang M; Wang H; Zhang L Medicine (Baltimore); 2023 May; 102(21):e33775. PubMed ID: 37233428 [TBL] [Abstract][Full Text] [Related]
10. [The mechanism of resistance to 2', 2'-difluorodeoxycytidine (gemcitabine) in a pancreatic cancer cell line]. Yao J; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Yang Y Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):721-6. PubMed ID: 16483481 [TBL] [Abstract][Full Text] [Related]
11. TRIM29 facilitates gemcitabine resistance via MEK/ERK pathway and is modulated by circRPS29/miR-770-5p axis in PDAC. Huang W; Hu X; He X; Pan D; Huang Z; Gu Z; Huang G; Wang P; Cui C; Fan Y Drug Resist Updat; 2024 May; 74():101079. PubMed ID: 38518727 [TBL] [Abstract][Full Text] [Related]
12. Identification of chemoresistance-related mRNAs based on gemcitabine-resistant pancreatic cancer cell lines. Zhou J; Zhang L; Zheng H; Ge W; Huang Y; Yan Y; Zhou X; Zhu W; Kong Y; Ding Y; Wang W Cancer Med; 2020 Feb; 9(3):1115-1130. PubMed ID: 31823522 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Giovannetti E; Funel N; Peters GJ; Del Chiaro M; Erozenci LA; Vasile E; Leon LG; Pollina LE; Groen A; Falcone A; Danesi R; Campani D; Verheul HM; Boggi U Cancer Res; 2010 Jun; 70(11):4528-38. PubMed ID: 20460539 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells. Nagano H; Tomimaru Y; Eguchi H; Hama N; Wada H; Kawamoto K; Kobayashi S; Mori M; Doki Y Int J Oncol; 2013 Oct; 43(4):1066-72. PubMed ID: 23900458 [TBL] [Abstract][Full Text] [Related]
15. Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer. Yu S; Wang M; Zhang H; Guo X; Qin R J Cell Mol Med; 2024 Jun; 28(12):e18444. PubMed ID: 38924205 [TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer. Gu J; Huang W; Wang X; Zhang J; Tao T; Zheng Y; Liu S; Yang J; Chen ZS; Cai CY; Li J; Wang H; Fan Y Mol Cancer; 2022 May; 21(1):112. PubMed ID: 35538494 [TBL] [Abstract][Full Text] [Related]
17. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer. Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207 [TBL] [Abstract][Full Text] [Related]
18. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating Integrin β1. Yang D; Hu Z; Xu J; Tang Y; Wang Y; Cai Q; Zhu Z Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693728 [TBL] [Abstract][Full Text] [Related]
19. Identifying genes with differential expression in gemcitabine-resistant pancreatic cancer cells using comprehensive transcriptome analysis. Nakai Y; Otsuka M; Hoshida Y; Tada M; Komatsu Y; Kawabe T; Omata M Oncol Rep; 2005 Nov; 14(5):1263-7. PubMed ID: 16211294 [TBL] [Abstract][Full Text] [Related]
20. Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing. Li D; Qian X; Xu P; Wang X; Li Z; Qian J; Yao J DNA Cell Biol; 2018 Oct; 37(10):839-849. PubMed ID: 30113217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]